THAT:

p0.68

UNCH

Thalia Therapeutics Plc

GBX as of Aug 3, 2026 | LSE - London Stock Exchange

Company Profile FTSE AIM All-Share

1-Year Price Evolution & Moving Averages

1-Year: +50.00%

Multi-timeframe price chart with technical indicators - Penny sterling (GBX)

Company Description

Company Profile

Thalia Therapeutics Plc is a biotechnology company developing RNA-based therapeutics and delivery technologies for oncology and cardiovascular disease. The company's proprietary Nuvec delivery system uses amorphous silica nanoparticles with an irregular surface structure designed to trap, protect, and deliver RNA molecules intracellularly. This silica-based platform can be functionalized with proteins, peptides, antibodies, or radionuclides for targeted therapeutic applications. Additionally, Thalia Therapeutics develops LipTide, a lipid and peptide-based delivery system that mimics natural virus mechanisms for efficient cellular RNA delivery. The company maintains a growing pipeline of RNA-based programs focusing on dual-target cardiovascular treatments, including a novel long-duration siRNA program targeting PCSK9 and lipoprotein. Thalia Therapeutics addresses key limitations in existing nucleic acid delivery systems, offering potential applications across gene therapy, cancer therapeutics, and vaccine development. The company operates as a pre-clinical stage specialist pharmaceutical enterprise, making its technologies available for licensing to pharmaceutical and biotech partners.

United Kingdom Healthcare Biotechnology UK Healthcare UK Biotechnology

Risk & Valuation

as of Jul. 21, 2026

Beta	0.71
Trailing PE	-382.35
Forward PE

Stock Data

Open	p0.68
High	p0.68
Low	p0.65
Close	p0.68
Volume	253,239
Previous Close	p0.68
1-Day Change	0.00
1-Year Change	+0.23
Average Daily Volume	1,547,764
52-Week High	p0.73
52-Week Low	p0.43

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.